Cardiac amyloidosisImagingRadiology99mTc-PYP imagingCardiac magnetic resonance imagingPET/CTCardiac CTAPurpose of review Imaging of cardiac amyloidosis has traditionally been hindered by nonspecific findings or diagnosis late in disease. Recent imaging techniques aim to address these gaps. Recent findings T1 ...
Fontana, M. et al. Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study.Radiology277, 388–397 (2015). Google Scholar Martinez-Naharro, A. et al. Native T1 and extracellular volume in transthyretin amyloidosis.JACC ...
A positive result for myocardial biopsy, cardiac MRI or PYP scan was considered to be diagnostic and the date of whichever study came first defined as the diagnosis date. For cases where providers noted a strong suspicion of amyloidosis on TTE before subsequent confirmation by another modality, ...
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging Circ Cardiovasc Imaging., 14 (2021) e000029 Google Scholar 36 T. Lane, M. Fontana, A. Martinez-Naharro, et al...
Aim of this study is the analysis of clinical, morphologic and haemodynamic features of cardiac amyloidosis. Cardiac amyloidosis was demonstrated histologically in 7 of our patients: in 6 by endomyocardial biopsy during cardiac catheterization, in one at autopsy. The clinical picture was characterized ...
(99mTc-DPD) 738 Volume 19 | Number 7 | July 2017 | GENETICS in MEDICINE Cardiac amyloidosis in elderly African Americans | BUXBAUM and RUBERG Review in Europe53 or with 99mTc-PYP (pyrophosphate) in the United States.54 Although minimal uptake is seen in cardiac AL depo- sition, greater ...
To validate the significance of technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in diagnosing cardiac amyloidosis, 2 patients with famili... M Takezaki,Y Ishida,T Morozumi,... - 《Kaku Igaku》 被引量: 13发表: 1989年 加载更多来源...
Treatment of transthyretin cardiac amyloidosis Tafamidis is currently the only approved disease-modifying treatment for ATTR-CM. However, there have been important developments in the treatment of ATTR-... D Bampatsias,A Wardhere,MS Maurer - 《Current Opinion in Cardiology》...
Transthyretin cardiac amyloidosis99mTc-Pyrophosphate imagingDiagnosisRisk stratificationSPECT/CTThis review evaluates recent advancements in Technetium-99m pyrophosphate (99mTc-PYP) imaging for transthyretin amyloid cardiomyopathy (ATTR-CM). We summarize the advantages of single-photon emission computed tomography ...
Molecular imagingPETAmyloid heart diseasePyrophosphate (PYP) scintigraphy provides high diagnostic accuracy for the detection of transthyretin (ATTR) cardiac amyloidosis (CA). There has recently been emerging interest in using 18F-sodium fluoride (NaF) for this application, yet its sensitivity has never...